<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://science-nature.marc8.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>clinical trial</title>
 <link>http://science-nature.marc8.com/news-tags/clinical-trial</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>Researchers Discover New Risk Factor For Cardiovascular Disease,...</title>
 <link>http://science-nature.marc8.com/researchers-discover-new-risk-factor-cardiovascular-disease</link>
 <description>&lt;p&gt;Scientists have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease. The results of the study were so conclusive that the clinical trial had to be stopped before its scheduled completion date.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/447603123&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/researchers-discover-new-risk-factor-cardiovascular-disease#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/cardiovascular-disease">cardiovascular disease</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/completion-date">completion date</category>
 <category domain="http://science-nature.marc8.com/news-tags/protein">protein</category>
 <category domain="http://science-nature.marc8.com/news-tags/risk-factor">risk factor</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/11011</wfw:commentRss>
 <pubDate>Mon, 10 Nov 2008 00:00:36 -0600</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">11011 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Science in the News - Monday 3 November 2008</title>
 <link>http://science-nature.marc8.com/science-news-monday-3-november-2008</link>
 <description>&lt;p&gt;Hundreds of motor neurone disease sufferers are to be given a daily lithium pill in a clinical trial of a possible treatment for the devastating condition.&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/science-news-monday-3-november-2008#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/3-november">3 november</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/disease-sufferers">disease sufferers</category>
 <category domain="http://science-nature.marc8.com/news-tags/motor-neurone-disease">motor neurone disease</category>
 <category domain="http://science-nature.marc8.com/news-tags/science-news">science in the news</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/10690</wfw:commentRss>
 <pubDate>Sun, 02 Nov 2008 18:00:00 -0600</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">10690 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Clinical Trial For New Tuberculosis Vaccine</title>
 <link>http://science-nature.marc8.com/clinical-trial-new-tuberculosis-vaccine-0</link>
 <description>&lt;p&gt;With annually 2 million deaths and 9 million new cases, there are more victims of tuberculosis than of any other infectious disease, apart from AIDS. Worsening the situation, many strains of tuberculosis are so resistant that they no longer respond to traditional treatment, making the necessity of a new tuberculosis vaccine more urgent than ever. For the first time in 80 years, a promising live tuberculosis vaccine has reached the clinical trial stage in Germany.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/389737608&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/clinical-trial-new-tuberculosis-vaccine-0#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/infectious-disease">infectious disease</category>
 <category domain="http://science-nature.marc8.com/news-tags/trial-stage">trial stage</category>
 <category domain="http://science-nature.marc8.com/news-tags/tuberculosis">tuberculosis</category>
 <category domain="http://science-nature.marc8.com/news-tags/tuberculosis-vaccine">tuberculosis vaccine</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/8062</wfw:commentRss>
 <pubDate>Fri, 12 Sep 2008 11:30:09 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8062 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Clinical trial for new tuberculosis vaccine</title>
 <link>http://science-nature.marc8.com/clinical-trial-new-tuberculosis-vaccine</link>
 <description>&lt;p&gt;(Max-Planck-Gesellschaft) With annually 2 million deaths and 9 million new cases, there are more victims of tuberculosis than of any other infectious disease, apart from AIDS. Worsening the situation, many strains of tuberculosis are so resistant that they no longer respond to traditional treatment, making the necessity of a new tuberculosis vaccine more urgent than ever. For the first time in 80 years, a promising live tuberculosis vaccine has reached the clinical trial stage in Germany.&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/clinical-trial-new-tuberculosis-vaccine#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/max-planck">max planck</category>
 <category domain="http://science-nature.marc8.com/news-tags/max-planck-gesellschaft">max planck gesellschaft</category>
 <category domain="http://science-nature.marc8.com/news-tags/trial-stage">trial stage</category>
 <category domain="http://science-nature.marc8.com/news-tags/tuberculosis-vaccine">tuberculosis vaccine</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/7991</wfw:commentRss>
 <pubDate>Thu, 11 Sep 2008 00:00:00 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7991 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Novel tuberculosis vaccine in Germany in clinical phase</title>
 <link>http://science-nature.marc8.com/novel-tuberculosis-vaccine-germany-clinical-phase</link>
 <description>&lt;p&gt;(Helmholtz Association of German Research Centres) For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation &quot;VPM1002&quot;, has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany.&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/novel-tuberculosis-vaccine-germany-clinical-phase#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-phase">clinical phase</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/german-research">german research</category>
 <category domain="http://science-nature.marc8.com/news-tags/neuss-germany">neuss germany</category>
 <category domain="http://science-nature.marc8.com/news-tags/tuberculosis-vaccine">tuberculosis vaccine</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/7992</wfw:commentRss>
 <pubDate>Thu, 11 Sep 2008 00:00:00 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7992 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>For Coronary Artery Disease Patients, B Vitamins May Not Reduce ...</title>
 <link>http://science-nature.marc8.com/coronary-artery-disease-patients-b-vitamins-may-not-reduce</link>
 <description>&lt;p&gt;In a large clinical trial involving patients with coronary artery disease, use of B vitamins was not effective for preventing death or cardiovascular events, according to a study published in the Aug. 20 issue of JAMA.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/371988282&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/coronary-artery-disease-patients-b-vitamins-may-not-reduce#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/b-vitamins">b vitamins</category>
 <category domain="http://science-nature.marc8.com/news-tags/cardiovascular-events">cardiovascular events</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/coronary-artery-disease">coronary artery disease</category>
 <category domain="http://science-nature.marc8.com/news-tags/disease-patients">disease patients</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/7099</wfw:commentRss>
 <pubDate>Fri, 22 Aug 2008 13:15:22 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7099 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>First Gene Therapy For Heart Failure Offered In Clinical Trials</title>
 <link>http://science-nature.marc8.com/first-gene-therapy-heart-failure-offered-clinical-trials</link>
 <description>&lt;p&gt;Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/315012380&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/first-gene-therapy-heart-failure-offered-clinical-trials#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trials">clinical trials</category>
 <category domain="http://science-nature.marc8.com/news-tags/gene-therapy">gene therapy</category>
 <category domain="http://science-nature.marc8.com/news-tags/heart-failure">heart failure</category>
 <category domain="http://science-nature.marc8.com/news-tags/physician-scientists">physician scientists</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/5440</wfw:commentRss>
 <pubDate>Wed, 18 Jun 2008 21:30:23 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">5440 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Are HIV Prevention Gels Safe For Pregnant Women, Their Babies?</title>
 <link>http://science-nature.marc8.com/are-hiv-prevention-gels-safe-pregnant-women-their-babies</link>
 <description>&lt;p&gt;Clinical trials hoping to identify a vaginal microbicide that is safe and effective against HIV have all but skirted questions befitting evaluation of an approach intended primarily for sexually active women of childbearing age: What if a woman gets pregnant while using a product? Can exposure during pregnancy pose a risk to the fetus? Researchers will begin addressing these and other questions in the first clinical trial of a candidate vaginal microbicide in pregnant women.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/310430344&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/are-hiv-prevention-gels-safe-pregnant-women-their-babies#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/fetus">fetus</category>
 <category domain="http://science-nature.marc8.com/news-tags/hiv-prevention">hiv prevention</category>
 <category domain="http://science-nature.marc8.com/news-tags/microbicide">microbicide</category>
 <category domain="http://science-nature.marc8.com/news-tags/pregnant-women">pregnant women</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/5381</wfw:commentRss>
 <pubDate>Mon, 16 Jun 2008 18:45:10 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">5381 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Blood Substitute&#039;s Effectiveness And Safety Addressed In Large C...</title>
 <link>http://science-nature.marc8.com/blood-substitutes-effectiveness-and-safety-addressed-large-c</link>
 <description>&lt;p&gt;A blood substitute&#039;s effectiveness and safety was addressed in a large Phase III clinical trial by academic and industry researchers.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/311208021&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/blood-substitutes-effectiveness-and-safety-addressed-large-c#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/blood-substitute">blood substitute</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/industry-researchers">industry researchers</category>
 <category domain="http://science-nature.marc8.com/news-tags/phase-iii">phase iii</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/5322</wfw:commentRss>
 <pubDate>Fri, 13 Jun 2008 11:45:20 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">5322 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Trial is first to see if HIV prevention gels are safe for pregna...</title>
 <link>http://science-nature.marc8.com/trial-first-see-if-hiv-prevention-gels-are-safe-pregna</link>
 <description>&lt;p&gt;(Microbicide Trials Network) Clinical trials hoping to identify a vaginal microbicide that is safe and effective against HIV have all but skirted questions befitting evaluation of an approach intended primarily for sexually active women of childbearing age: What if a woman gets pregnant while using a product? Can exposure during pregnancy pose a risk to the fetus? Researchers will begin addressing these and other questions in the first clinical trial of a candidate vaginal microbicide in pregnant women.&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/trial-first-see-if-hiv-prevention-gels-are-safe-pregna#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/clinical-trial">clinical trial</category>
 <category domain="http://science-nature.marc8.com/news-tags/fetus">fetus</category>
 <category domain="http://science-nature.marc8.com/news-tags/gels">gels</category>
 <category domain="http://science-nature.marc8.com/news-tags/hiv-prevention">hiv prevention</category>
 <category domain="http://science-nature.marc8.com/news-tags/pregnant-women">pregnant women</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/5279</wfw:commentRss>
 <pubDate>Thu, 12 Jun 2008 00:00:00 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">5279 at http://science-nature.marc8.com</guid>
</item>
</channel>
</rss>
